ABCB1 and cancer: The MDR1 efflux pump, or P-glycoprotein, often overexpressed in drug-resistant cancer cells, poses a significant challenge in cancer treatment by actively expelling chemotherapeutic drugs, reducing their intracellular concentrations and effectiveness [112].